Form 4: Tectonic Therapeutic CBO Sells Shares for Tax

Tectonic Therapeutic's Chief Business Officer, Marc Schwabish, disposed of 1,619 common shares to cover tax obligations related to restricted stock unit vesting.

Summary

• Marc Schwabish, Chief Business Officer of Tectonic Therapeutic, Inc. (TECX), reported a transaction on February 4, 2026.
• The transaction involved the disposition of 1,619 shares of common stock.
• The shares were disposed of at a price of $23.22 per share.
• This disposition was a withholding of shares by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
• The restricted stock units were originally granted on February 4, 2025.
• Following this transaction, Marc Schwabish beneficially owns 21,314 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The transaction is a standard administrative procedure for executive compensation and does not indicate a change in the company's operational or financial health.

Positives

• The underlying event, the vesting of restricted stock units, represents a successful milestone for the executive's compensation plan.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that tax-related sales by insiders, such as those to cover withholding obligations upon restricted stock unit vesting, are common and typically do not reflect a change in management's outlook on the company's future prospects. These are administrative transactions inherent to executive compensation structures.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a non-discretionary, tax-related sale and does not signal a change in the insider's investment conviction.

Key Dates

Recommendation

The transaction is a non-discretionary sale of shares to cover tax obligations upon RSU vesting, which is a common and expected event for executive compensation. It provides no new fundamental information to alter an investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

Tectonic Therapeutic, TECX, Form 4, Insider Transaction, Stock Sale, Tax Withholding, RSU Vesting, Marc Schwabish